Gonal-f ® RFF Redi-ject™ (follitropin alfa injection) is indicated for: Induction of ovulation and pregnancy in oligo-anovulatory women in whom the cause of infertility is functional and not due to ...
EMD Serono announced that Gonal-f RFF Redi-ject (recombinant follitropin alfa), a disposable prefilled drug injector pen intended for subcutaneous injection of a liquid formulation of Gonal-f RFF ...
Merck Serono announced that the FDA has approved EMD Serono‘s GONAL-f RFF Redi-ject (recombinant follitropin alfa) injection, a disposable prefilled drug injector pen indicated for the subcutaneous ...
BOSTON, February 06, 2026--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump's administration, ...
GENEVA, July 4, 2011 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission (EC) has granted an approval for three pre-filled, ...
EMD Serono, the U.S. healthcare business of Germany's Merck KGaA (OTCPK:MKGAF), has brokered an agreement with the Trump administration to provide its in vitro fertilization at a deep discount to US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results